Schneeweiss, A. (2014). Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: An exploratory analysis of the TRYPHAENA study. Breast cancer research, 16(4), . https://doi.org/10.1186/bcr3690
Chicago-Zitierstil (17. Ausg.)Schneeweiss, Andreas. "Evaluating the Predictive Value of Biomarkers for Efficacy Outcomes in Response to Pertuzumab- and Trastuzumab-based Therapy: An Exploratory Analysis of the TRYPHAENA Study." Breast Cancer Research 16, no. 4 (2014). https://doi.org/10.1186/bcr3690.
MLA-Zitierstil (9. Ausg.)Schneeweiss, Andreas. "Evaluating the Predictive Value of Biomarkers for Efficacy Outcomes in Response to Pertuzumab- and Trastuzumab-based Therapy: An Exploratory Analysis of the TRYPHAENA Study." Breast Cancer Research, vol. 16, no. 4, 2014, https://doi.org/10.1186/bcr3690.